Literature DB >> 1587507

What we know about homelessness among mentally ill persons: an analytical review and commentary.

L L Bachrach1.   

Abstract

Although extensive research on the homeless mentally ill population has been conducted, existing studies have failed to answer three important questions: the prevalence of chronic mental illness among homeless persons, whether deinstitutionalization has precipitated increased homelessness in this population, and what kinds of services should be offered. The author suggests that future research will require clearer definition of the terms used in discussing this population and calls for increased federal direction in making policies to respond to their problems, especially the problems of those who are geographically mobile. Successful service planning must address the full array of disabilities experienced by homeless mentally ill persons, including psychiatric symptoms, secondary responses to the experience of illness, and disabilities resulting from stigma and lack of societal opportunity.

Entities:  

Mesh:

Year:  1992        PMID: 1587507     DOI: 10.1176/ps.43.5.453

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  4 in total

1.  Mental illness in homeless women: an epidemiological study in Munich, Germany.

Authors:  A Greifenhagen; M Fichter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

2.  Discrimination and exiting homelessness among homeless adolescents.

Authors:  Norweeta G Milburn; George Ayala; Eric Rice; Philip Batterham; Mary Jane Rotheram-Borus
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2006-10

3.  Use of psychiatric services by homeless veterans.

Authors:  J Stovall; J A Flaherty; B Bowden; M Schoeny
Journal:  J Ment Health Adm       Date:  1997

4.  Are rates of psychiatric disorders in the homeless population changing?

Authors:  Carol S North; Karin M Eyrich; David E Pollio; Edward L Spitznagel
Journal:  Am J Public Health       Date:  2004-01       Impact factor: 9.308

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.